Gerard Cremoux - Latamgrowth SPAC CFO CEO
| LATGU Stock | USD 11.77 0.14 1.20% |
Insider
Gerard Cremoux is CFO CEO of Latamgrowth SPAC Unit
| Age | 52 |
| Address | No. 29-11, South Beach Tower, Singapore, Singapore, 189767 |
| Phone | 65 9851 8611 |
| Web | https://chengheinv.com/chenghe-acquisition-i-co |
Latamgrowth SPAC Management Efficiency
The company has return on total asset (ROA) of (0.0297) % which means that it has lost $0.0297 on every $100 spent on assets. This is way below average. Latamgrowth SPAC's management efficiency ratios could be used to measure how well Latamgrowth SPAC manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Latamgrowth SPAC's Return On Tangible Assets are comparatively stable compared to the past year. Return On Assets is likely to gain to 0.01 in 2024, despite the fact that Return On Capital Employed is likely to grow to (0.05). Liabilities And Stockholders Equity is likely to gain to about 65.9 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 1.1 M in 2024.Similar Executives
| Showing other executives | INSIDER Age | ||
| Anne Pascard | ABIVAX Socit Anonyme | N/A | |
| Ann Challis | Goosehead Insurance | N/A | |
| Julia Jordan | Goosehead Insurance | N/A | |
| Raquel Lizarraga | ABIVAX Socit Anonyme | N/A | |
| Jose Teixeira | Patria Latin American | 45 | |
| Philippe MD | ABIVAX Socit Anonyme | 65 | |
| Prof Ehrlich | ABIVAX Socit Anonyme | N/A | |
| Leslie Wojcik | SEI Investments | N/A | |
| Marco DIppolito | Patria Latin American | 47 | |
| Alain Chevallier | ABIVAX Socit Anonyme | 70 | |
| Jared Sinclair | Goosehead Insurance | N/A | |
| Regina Jehle | ABIVAX Socit Anonyme | N/A | |
| Paul Gineste | ABIVAX Socit Anonyme | N/A | |
| James Smigiel | SEI Investments | 55 | |
| Pierre MBA | ABIVAX Socit Anonyme | N/A | |
| Joe McCabe | SEI Investments | N/A | |
| Patrick Langston | Goosehead Insurance | 42 | |
Management Performance
| Return On Asset | -0.0297 |
Latamgrowth SPAC Unit Leadership Team
Elected by the shareholders, the Latamgrowth SPAC's board of directors comprises two types of representatives: Latamgrowth SPAC inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Latamgrowth. The board's role is to monitor Latamgrowth SPAC's management team and ensure that shareholders' interests are well served. Latamgrowth SPAC's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Latamgrowth SPAC's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yixuan Yuan, Chief Officer | ||
| Gerard Cremoux, CFO CEO | ||
| Zhaohai Wang, Chief Officer | ||
| Hector Duro, Managing Director | ||
| Gerardo Mendoza, Chief Officer | ||
| Miguel Olea, Managing Director | ||
| Zhiyang Zhou, President |
Latamgrowth Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Latamgrowth SPAC a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.0297 | |||
| Current Valuation | 80.62 M | |||
| Shares Owned By Institutions | 3.95 % | |||
| EBITDA | 2.57 M | |||
| Net Income | 425.91 K | |||
| Cash And Equivalents | 1.41 M | |||
| Cash Per Share | 0.09 X | |||
| Total Debt | 404.17 K | |||
| Book Value Per Share | (0.31) X | |||
| Cash Flow From Operations | (747.38 K) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Latamgrowth Stock Analysis
When running Latamgrowth SPAC's price analysis, check to measure Latamgrowth SPAC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Latamgrowth SPAC is operating at the current time. Most of Latamgrowth SPAC's value examination focuses on studying past and present price action to predict the probability of Latamgrowth SPAC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Latamgrowth SPAC's price. Additionally, you may evaluate how the addition of Latamgrowth SPAC to your portfolios can decrease your overall portfolio volatility.